Learn More
CLN6 Rabbit anti-Human, Polyclonal Antibody, Abnova™
Rabbit polyclonal antibody raised against synthetic peptide of CLN6.
Supplier: Abnova Corporation PAB25102
Description
This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function. [provided by RefSeq
Specifications
CLN6 | |
Polyclonal | |
Unconjugated | |
Western Blot (1:500-1:1000) Immunohistochemistry (1:50-1:200) The optimal working dilution should be determined by the end user. | |
CLN6 | |
CLN6 | |
A synthetic peptide corresponding to CLN6. | |
100 μL | |
Primary | |
CLN6 polyclonal antibody detects endogenous levels of CLN6 protein. | |
Store at 4°C. For long term storage store at -20°C. Aliquot to avoid repeated freezing and thawing. |
Immunohistochemistry (PFA fixed), Western Blot | |
1 mg/mL | |
Rabbit polyclonal antibody raised against synthetic peptide of CLN6. | |
In PBS, pH 7.2 (0.05% sodium azide) | |
FLJ20561/HsT18960/nclf | |
Rabbit | |
Affinity purification | |
RUO | |
54982 | |
Human | |
Liquid |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
For Research Use Only